CN102150779B - Health food for regulating and stabilizing blood sugar and preparation method thereof - Google Patents
Health food for regulating and stabilizing blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN102150779B CN102150779B CN2011100720102A CN201110072010A CN102150779B CN 102150779 B CN102150779 B CN 102150779B CN 2011100720102 A CN2011100720102 A CN 2011100720102A CN 201110072010 A CN201110072010 A CN 201110072010A CN 102150779 B CN102150779 B CN 102150779B
- Authority
- CN
- China
- Prior art keywords
- blood sugar
- health food
- root
- reaches
- wheat bran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims abstract description 55
- 210000004369 blood Anatomy 0.000 title claims abstract description 55
- 235000013402 health food Nutrition 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 230000001105 regulatory effect Effects 0.000 title abstract description 3
- 230000000087 stabilizing effect Effects 0.000 title abstract 3
- 244000068988 Glycine max Species 0.000 claims abstract description 27
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 27
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 18
- 239000000654 additive Substances 0.000 claims abstract description 15
- 230000000996 additive effect Effects 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 20
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 15
- 235000005412 red sage Nutrition 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 244000268590 Euryale ferox Species 0.000 claims description 13
- 235000006487 Euryale ferox Nutrition 0.000 claims description 13
- 244000197580 Poria cocos Species 0.000 claims description 13
- 235000008599 Poria cocos Nutrition 0.000 claims description 13
- 244000046146 Pueraria lobata Species 0.000 claims description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 13
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 11
- 239000000811 xylitol Substances 0.000 claims description 11
- 235000010447 xylitol Nutrition 0.000 claims description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 11
- 229960002675 xylitol Drugs 0.000 claims description 11
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 10
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 229930003471 Vitamin B2 Natural products 0.000 claims description 10
- 229940093503 ethyl maltol Drugs 0.000 claims description 10
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 10
- 229960002477 riboflavin Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 235000019164 vitamin B2 Nutrition 0.000 claims description 10
- 239000011716 vitamin B2 Substances 0.000 claims description 10
- 235000019158 vitamin B6 Nutrition 0.000 claims description 10
- 239000011726 vitamin B6 Substances 0.000 claims description 10
- 229940011671 vitamin b6 Drugs 0.000 claims description 10
- 235000013175 Crataegus laevigata Nutrition 0.000 claims description 3
- 239000002932 luster Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 17
- 235000005911 diet Nutrition 0.000 abstract description 13
- 241001092040 Crataegus Species 0.000 abstract description 11
- 230000037213 diet Effects 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 241001107116 Castanospermum australe Species 0.000 abstract 4
- 235000021279 black bean Nutrition 0.000 abstract 4
- 241001061264 Astragalus Species 0.000 abstract 3
- 235000017276 Salvia Nutrition 0.000 abstract 3
- 235000006533 astragalus Nutrition 0.000 abstract 3
- 210000004233 talus Anatomy 0.000 abstract 3
- 208000002705 Glucose Intolerance Diseases 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 28
- 239000000047 product Substances 0.000 description 21
- 239000000203 mixture Substances 0.000 description 16
- 238000009472 formulation Methods 0.000 description 15
- 230000036541 health Effects 0.000 description 15
- 235000013325 dietary fiber Nutrition 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 230000037396 body weight Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 229940126680 traditional chinese medicines Drugs 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 108010001483 Glycogen Synthase Proteins 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 208000032781 Diabetic cardiomyopathy Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229940122199 Insulin secretagogue Drugs 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 102000005765 Proto-Oncogene Proteins c-akt Human genes 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 101000600752 Rattus norvegicus 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005118 dietary health Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 101150107521 eat-20 gene Proteins 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100720102A CN102150779B (en) | 2011-03-24 | 2011-03-24 | Health food for regulating and stabilizing blood sugar and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100720102A CN102150779B (en) | 2011-03-24 | 2011-03-24 | Health food for regulating and stabilizing blood sugar and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102150779A CN102150779A (en) | 2011-08-17 |
CN102150779B true CN102150779B (en) | 2012-11-21 |
Family
ID=44432708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100720102A Expired - Fee Related CN102150779B (en) | 2011-03-24 | 2011-03-24 | Health food for regulating and stabilizing blood sugar and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102150779B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105341760A (en) * | 2015-11-04 | 2016-02-24 | 伍月霞 | Composition for treating diabetes as well as preparation method and application of composition |
CN107348331A (en) * | 2017-06-12 | 2017-11-17 | 金梅 | A kind of alimentation composition for Impaired Glucose Regulation and preparation method thereof |
CN115998803B (en) * | 2023-01-09 | 2023-11-17 | 南京中医药大学翰林学院 | Pharmaceutical composition for improving myocardial ischemia reperfusion injury and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108483A (en) * | 1994-03-12 | 1995-09-20 | 陈顺志 | Method for production of instant medicinal porridge |
CN1621085A (en) * | 2004-12-09 | 2005-06-01 | 王俊江 | Medicine for treating diabetes |
CN1626157A (en) * | 2003-12-12 | 2005-06-15 | 郭文轩 | Method for preparing oral liquid for lowering blood sugar |
CN101167846A (en) * | 2007-10-26 | 2008-04-30 | 刘会东 | Capsule with blood sugar reducing function and preparation method thereof |
CN101513492A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicament for treating diabetes |
CN101564163A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for reducing blood sugar and blood fat and preparation method thereof |
-
2011
- 2011-03-24 CN CN2011100720102A patent/CN102150779B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1108483A (en) * | 1994-03-12 | 1995-09-20 | 陈顺志 | Method for production of instant medicinal porridge |
CN1626157A (en) * | 2003-12-12 | 2005-06-15 | 郭文轩 | Method for preparing oral liquid for lowering blood sugar |
CN1621085A (en) * | 2004-12-09 | 2005-06-01 | 王俊江 | Medicine for treating diabetes |
CN101167846A (en) * | 2007-10-26 | 2008-04-30 | 刘会东 | Capsule with blood sugar reducing function and preparation method thereof |
CN101513492A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicament for treating diabetes |
CN101564163A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for reducing blood sugar and blood fat and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102150779A (en) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (en) | Health-care food for preventing diabetes | |
CN103229963B (en) | Coarse cereal food subjected to treatment of germination and preparation method of coarse cereal food | |
CN103504305B (en) | Health product with blood sugar reduction function and preparation method thereof | |
CN107897905A (en) | A kind of hypoglycemic nutrition powder and its preparation method and application | |
CN102524659A (en) | Grain formula with nutrition and health care functions | |
CN103141678B (en) | Composite goose feed containing Chinese medicinal herbs | |
CN102204649B (en) | Healthcare food for regulating and stabilizing blood sugar and method for preparing same | |
CN103211162A (en) | Fermented coarse cereal food and preparation method thereof | |
CN101564158A (en) | Natural five-color sugar-reducing nutritious noodle and method for preparing same | |
CN103168812A (en) | Sugar-free tartary buckwheat biscuit and manufacture method thereof | |
CN102178183A (en) | Five-bean comprehensive nutritional food | |
CN103141682B (en) | Composite duck feed containing Chinese medicinal herbs | |
CN109549097A (en) | A kind of health caring noodles with functions of reducing sugar and reducing fat | |
CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
CN105685191A (en) | Life-nourishing dendrobe cookies and preparation method thereof | |
CN104799177A (en) | Sweet potato-based nutritious porridge and preparation method | |
CN103141680B (en) | Composite cattle feed containing Chinese medicinal herbs | |
CN102150779B (en) | Health food for regulating and stabilizing blood sugar and preparation method thereof | |
CN105919089A (en) | Health-preserving chewable tablet compound capable of reducing blood lipid and reducing blood glucose as well as preparation method thereof | |
CN103238757B (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
CN106819799A (en) | A kind of health-care rice flour of confession infantile spleen deficiency edible for patients and preparation method thereof | |
CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
CN102987402B (en) | Plateau natural plant food with balance nutrition and preparation method thereof | |
CN102652561A (en) | Vegetable protein food for treating micro-disease or assisting medicament in rehabilitating sick body and production method thereof | |
CN105285976A (en) | Food granules having function of health care and use of food granules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WUHAN QIYAO ENVIRONMENT TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CEN WEIHUA Effective date: 20140421 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430022 WUHAN, HUBEI PROVINCE TO: 430000 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140421 Address after: 430000, No. 10, No. 2-402, sunshine online, 998 hung Chu street, East Lake Development Zone, Hubei, Wuhan Patentee after: WUHAN QIYAO ENVIRONMENTAL TECHNOLOGY CO.,LTD. Address before: 430022 World Trade Building No. 686, Jiefang Avenue, Jianghan District, Hubei, Wuhan 3004, China Patentee before: Cen Weihua |
|
CP03 | Change of name, title or address |
Address after: 430014 Room 523, Building 1, B, Headquarters of Gaonong Biological Park, 888 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan Qi Yao Biological Technology Co.,Ltd. Address before: 430000 Sunshine Online No. 2-402, No. 998 Xiongchu Street, Donghu Development Zone, Wuhan City, Hubei Province Patentee before: WUHAN QIYAO ENVIRONMENTAL TECHNOLOGY CO.,LTD. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190708 Address after: 430042 No. 43, Maomiao Market Street, Baiquan, Dongxihu District, Wuhan City, Hubei Province (9) Patentee after: Wuhan Taoyuanfeng Holding Co.,Ltd. Address before: 430014 Room 523, Building 1, B, Headquarters of Gaonong Biological Park, 888 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan Qi Yao Biological Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191126 Address after: 430000 room b011, public service center, daolongquan mountain scenic spot, 004 County, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan runshui Environmental Technology Co.,Ltd. Address before: 430042 No. 43, Maomiao Market Street, Baiquan, Dongxihu District, Wuhan City, Hubei Province (9) Patentee before: Wuhan Taoyuanfeng Holding Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121121 Termination date: 20210324 |